The aim of this work was to demonswate that the exorbital rat lacrimal gland was a site of synthesis of some growth factors of the EGF family (EGF, HB-EGF, TGFa) and their receptor, namely the EGF receptor ,FGFP\ \ --. . . , Methods: Male Sprague Dawley rats were used in these experhnents. RT-PCR and Northern-Blot analysis of the lacrimal gland mRNA population were pe~fotmcd to study the expression of both growth factors sod EGFR genes. The DKS~WX of EGF-like activities in the soluble fraction of the lacrimal eland was'analysed by radio-receptor assay (RRA) using the rat liver EGFR as binding unit and moose t?sI-EGF as radioligand. The presence of the EGFR protein was .issessed by:
\ --. . . , Methods: Male Sprague Dawley rats were used in these experhnents. RT-PCR and Northern-Blot analysis of the lacrimal gland mRNA population were pe~fotmcd to study the expression of both growth factors sod EGFR genes. The DKS~WX of EGF-like activities in the soluble fraction of the lacrimal eland was'analysed by radio-receptor assay (RRA) using the rat liver EGFR as binding unit and moose t?sI-EGF as radioligand. The presence of the EGFR protein was .issessed by: I/ Immunochemical techniques: immuooprecipiration sod Westem-blot analysis of solubilized membrtuie proteins using a specific Sheep polyclonal antibody directed against the human EGFR. Its activation by EGF was measulrd using a specific mouse moooclonal (4GlO) antrbody directed against phosphotyrosine residues 21 Radioligand binding experiments which were performed on membrane fractions usinr '?sI-EGF as a radiolinalld M Res& demonstrate that thi mRNA population extracted from the rat lacrimal gland contains specific transcripts coding for growth factors such as EGF, TGFn and HB-EGF as well as for the EGFR. EGF-like growth factors were detected by RRA in the soluble fraction sod an EGF activable EGFR found in the membrane fraction of the lacrimal gland. To evaluate ocular tindings upon uxposure to cat dander m a controlled environment cat room and IO deternlme the efficacy of topical kelorolac and oral tedenadme In this model.
&&&
Forty patients with kflOWf1 cat ailtrrgles were 6XpOSed 10 car dander for 90 minutes Muiriplo sy~ns and symptoms were evaluilled every 36 minutes using quostionnoires. slit lamp exammation. and pulmonary function testmg At least one week later, patients were randomized to three days of Ireaiment with eilhor 1) placebo drops Ulo and oral placebo BID, 2) xetorolnc drops QID and oral placebo BID, 3) plac8bo drops QID and oral lerfenidine BlD,4) ketorobc drops OID ar'd oral terfenadine BID, or ; this pre treatmerIt was followed by repeat exposure 10 cat dander. Data were analyzed by ono-way ANOVA.
&&)&
Cat-sensdive individuals consislently axhlblted signs and symptoms of allergy in rhe cat room. Group 2 (Kctorolac drops with oml placebo) experienced a greater reduction of ocular itching than the other groups (p=O.OS). Group 4 (Ketorolac drops with oral terierladine) also showed improvement in ocula: signs and symptoms, but did nor achieve statistical signiltcance bucluse ot low sublocI numbers. IWO patients were dismissed due to excessive systen~ic signs or symplot~ -W
The cat room is a safe, reliable. and repmduclble method lo challenge the eyes of cat-sensitlvo individuals.
Keiorolac showed a benebcial effect in controllmg ocular ilching. Ketorolac ana terienadme also improved patients signs and symptoms This is an elfeaive mu&l for studying oCu!ar aliergic tesponses and drug intorvenbon.
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